Moderna swings to profit as momentum for cancer vaccine builds — Live Feedhttps://www.live-feeds.com/feed/moderna-swings-to-profit-as-momentum-for-cancer-vaccine-buildsContinuously updated, source-cited coverage. Moderna Swings to Profit as Cancer Vaccine Momentum Buildshttps://www.live-feeds.com/feed/moderna-swings-to-profit-as-momentum-for-cancer-vaccine-buildshttps://www.live-feeds.com/feed/moderna-swings-to-profit-as-momentum-for-cancer-vaccine-builds#u187240Mon, 09 Nov 2026 08:40:58 +0000Moderna swung to a profit and raised its 2026 financial outlook, driven by strong international demand for its COVID-19 vaccine and growing momentum for its pipeline products. The company's chief executive officer stated that newer vaccines are gaining traction as the biotech firm looks to future growth from new products, including a flu vaccine and a personalized cancer treatment. Following the quarterly earnings report that beat forecasts, company shares jumped 10 percent.Why it mattersThe financial turnaround highlights stabilization in the market for COVID-19 immunizations alongside b